Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NovaBone is a leading medical device company specializing in the development and manufacturing of bioactive glass bone graft substitutes for regenerative medicine. The company's proprietary technology platform utilizes the osteostimulative properties of bioactive glass to accelerate bone regeneration in orthopedic, spinal, and dental applications. Their product portfolio includes various delivery formats such as putties, morsels, and minimally invasive systems designed to enhance surgical outcomes and simplify handling for clinicians. Since its acquisition by Halma in 2020, NovaBone has continued to expand its global footprint while maintaining its focus on innovative biomaterial solutions. The company is headquartered in Alachua, Florida, where it operates its primary research and manufacturing facilities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NovaBone.